NCT00004923View on ClinicalTrials.gov

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 30, 1999

Study Completion Date

May 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

docetaxel

DRUG

irinotecan hydrochloride

Trial Locations (2)

06520-8028

Yale Comprehensive Cancer Center, New Haven

06902

Bennett Cancer Center, Stamford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER